Insulet Corporation

PODD09 Dec 2024
Healthcare
$266.44
0.00 (-0.32%)
Lowest Today
$263.39
Highest Today
$267.06
Today’s Open
$266.44
Prev. Close
$265.47
52 Week High
$279.4
52 Week Low
$160.19
To Invest in Insulet Corporation

Insulet Corporation

Healthcare
PODD09 Dec 2024
0.00 (-0.32%)
1M
3M
6M
1Y
5Y
Low
$263.39
Day’s Range
High
$267.06
263.39
52 Week Low
$160.19
52-Week Range
52 Week High
$279.4
160.19
1 Day
-
1 Week
-0.3%
1 month return
-0.83%
3 month return
+21.17%
6 month return
+38.28%
1 Year return
+36.49%
3 Years return
-4.08%
5 Years return
+46.91%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
12.08
FMR Inc
11.36
Capital Research Global Investors
11.08
BlackRock Inc
8.64
Capital Group AMCAP Composite
4.6
VA CollegeAmerica Amcap 529A
4.6
State Street Corp
4.16

Market Status

Fundamentals
Market Cap
18620.99 mln
PB Ratio
16.79
PE Ratio
45.69
Enterprise Value
19265.04 mln
Total Assets
2588.2 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Organisation
Insulet Corporation
Employees
3000
Industry
Medical Devices
CEO
Dr. James R. Hollingshead Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities